Drug Target Insights

AboutScience Srl

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Drug Target Insights is an open-access journal published by AboutScience Srl in Italy, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,500 EUR. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
AboutScience Srl
ISSN
1177-3928
Country
Italy
Languages
english
Access
Open access
Declared publication charge
1,500 EUR
Articles in DOAJ
319
Declared review time
8 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2007-05-31
Indexing
DOAJ
APC
1,500 EUR
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

319

Most recent article

last month

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

240

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

27

i10-index

70

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2022-09-30
Added to DOAJ
2007-05-31
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
100%
ORCID iDs in current deposits
97%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity3
Alternate titles
DTI
Source type
journal
NLM unique ID (PubMed)
101310097
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
  • Pharmacological Effects of Natural Compounds
  • Pharmacological Effects of Natural Compounds
  • Gastrointestinal motility and disorders
  • Gastrointestinal motility and disorders
  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
Show all subjects (50)
  • Antibiotic Use and Resistance
  • Antibiotic Use and Resistance
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Drug Solubulity and Delivery Systems
  • RNA Interference and Gene Delivery
  • Traditional and Medicinal Uses of Annonaceae
  • Nanoparticle-Based Drug Delivery
  • Diet and metabolism studies
  • HIV/AIDS drug development and treatment
  • Microscopic Colitis
  • Medicinal Plants and Neuroprotection
  • Drug Solubulity and Delivery Systems
  • Traditional and Medicinal Uses of Annonaceae
  • RNA Interference and Gene Delivery
  • Nanoparticle-Based Drug Delivery
  • Diet and metabolism studies
  • Medicinal Plants and Neuroprotection
  • Microscopic Colitis
  • HIV/AIDS drug development and treatment
  • Neurogenesis and neuroplasticity mechanisms
  • Mitochondrial Function and Pathology
  • Parasites and Host Interactions
  • Nanoplatforms for cancer theranostics
  • Aquaculture disease management and microbiota
  • HIV Research and Treatment
  • Parasites and Host Interactions
  • Aquaculture disease management and microbiota
  • Inflammatory Bowel Disease
  • Mosquito-borne diseases and control
  • HIV Research and Treatment
  • Drug Transport and Resistance Mechanisms
  • Asthma and respiratory diseases
  • Nanoplatforms for cancer theranostics
  • Drug Transport and Resistance Mechanisms
  • Asthma and respiratory diseases
  • Neurogenesis and neuroplasticity mechanisms
  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments
  • Mosquito-borne diseases and control
  • Mitochondrial Function and Pathology
  • Inflammatory Bowel Disease

Keywords (DOAJ)

  • clinical therapeutics
  • molecular drug targets
  • disease-specific proteins

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: